Literature DB >> 2368436

Undescended parathyroid adenoma: an important etiology for failed operations for primary hyperparathyroidism.

D L Fraker1, J L Doppman, T H Shawker, S J Marx, A M Spiegel, J A Norton.   

Abstract

From July, 1982 to April, 1989, a total of 145 patients with persistent or recurrent primary hyperparathyroidism (HPT) were explored; 105 patients had an adenoma as the cause of HPT, and in 9 patients (9%), the abnormal gland was located at or superior to the carotid bifurcation (undescended parathyroid gland). These 9 patients had 14 prior explorations for HPT including 4 median sternotomies and 5 thyroidectomies. Each of the 9 patients was symptomatic of HPT, including bone disease in 8 of 9 patients and renal stones in 4 of 9 patients. Seven patients had an undescended parathyroid adenoma correctly localized preoperatively by ultrasound (n = 5), angiography (n = 5), venous sampling (n = 1), or computed tomography scan (n = 4). These 7 patients with accurate preoperative localization were explored by an incision anterior to the sternocleidomastoid muscle high in the neck that avoided the previous operative field and allowed rapid resection of the parathyroid adenoma. In the 2 patients who did not have accurate preoperative localization, the undescended adenoma was found after long tedious exploration including median sternotomy in 1 patient. Each patient (n = 9) who had an undescended parathyroid adenoma removed was cured of hypercalcemia, and 5 patients required postoperative 1,25-dihydroxy vitamin D3 for hypocalcemia. We conclude that undescended parathyroid adenomas comprise a significant proportion (9%) of adenomas during reoperations for persistent HPT.(ABSTRACT TRUNCATED AT 250 WORDS)

Entities:  

Mesh:

Year:  1990        PMID: 2368436     DOI: 10.1007/bf01658522

Source DB:  PubMed          Journal:  World J Surg        ISSN: 0364-2313            Impact factor:   3.352


  21 in total

1.  Reoperative parathyroid surgery.

Authors:  R M Beazley; J Costa; A S Ketcham
Journal:  Am J Surg       Date:  1975-10       Impact factor: 2.565

2.  Clinical management of persistent and/or recurrent primary hyperparathyroidism.

Authors:  C S Grant; J A van Heerden; J W Charboneau; E M James; C C Reading
Journal:  World J Surg       Date:  1986-08       Impact factor: 3.352

3.  Parathymic parathyroid: CT, US, and angiographic findings.

Authors:  J L Doppman; T H Shawker; A G Krudy; D L Miller; S J Marx; A M Spiegel; J A Norton; M F Brennan; M Schaaf; G D Aurbach
Journal:  Radiology       Date:  1985-11       Impact factor: 11.105

4.  Localizing studies in patients with persistent or recurrent hyperparathyroidism.

Authors:  K E Levin; G A Gooding; M Okerlund; C B Higgins; D Norman; T H Newton; Q Y Duh; C D Arnaud; A E Siperstein; Q H Zeng
Journal:  Surgery       Date:  1987-12       Impact factor: 3.982

5.  Reoperation for primary hyperparathyroidism.

Authors:  P O Granberg; G Johansson; N Lindvall; U Ohman; A Wajngot; S Werner; J S Willems
Journal:  Am J Surg       Date:  1982-03       Impact factor: 2.565

6.  Results of reoperation for hyperparathyroidism, with evaluation of preoperative localization studies.

Authors:  A J Edis; P F Sheedy; O H Beahrs; J A van Heerden
Journal:  Surgery       Date:  1978-09       Impact factor: 3.982

7.  Surgical anatomy of human parathyroid glands.

Authors:  G Akerström; J Malmaeus; R Bergström
Journal:  Surgery       Date:  1984-01       Impact factor: 3.982

8.  Reoperative parathyroid surgery for persistent hyperparathyroidism.

Authors:  M F Brennan; J L Doppman; S J Marx; A M Spiegel; E M Brown; G D Aurbach
Journal:  Surgery       Date:  1978-06       Impact factor: 3.982

9.  Primary hyperparathyroidism. Incidence, morbidity, and potential economic impact in a community.

Authors:  H Heath; S F Hodgson; M A Kennedy
Journal:  N Engl J Med       Date:  1980-01-24       Impact factor: 91.245

10.  Lessons of parathyroid reoperations.

Authors:  K H Cohn; W Silen
Journal:  Am J Surg       Date:  1982-11       Impact factor: 2.565

View more
  9 in total

1.  Localization of parathyroid tumors using endoscopic ultrasonography in primary hyperparathyroidism.

Authors:  B Catargi; J M Raymond; V Lafarge-Gense; F Leccia; P Roger; A Tabarin
Journal:  J Endocrinol Invest       Date:  1999-10       Impact factor: 4.256

2.  Undescended parathyroid adenomas as cause of persistent hyperparathyroidism.

Authors:  Paula Rioja; Germán Mateu; Leyre Lorente-Poch; Juan J Sancho; Antonio Sitges-Serra
Journal:  Gland Surg       Date:  2015-08

3.  Management of patients with persistent or recurrent primary hyperparathyroidism.

Authors:  S E Carty; J A Norton
Journal:  World J Surg       Date:  1991 Nov-Dec       Impact factor: 3.352

4.  Reoperation for primary hyperparathyroidism: tips and tricks.

Authors:  Jean-François Henry
Journal:  Langenbecks Arch Surg       Date:  2010-02       Impact factor: 3.445

5.  Undescended parathyroid adenoma.

Authors:  Melissa D Kanack; Ali A Maawy; Deborah K Oh; Michael Bouvet
Journal:  BMJ Case Rep       Date:  2015-03-03

6.  Persistent primary hyperparathyroidism caused by adenomas identified in pharyngeal or adjacent structures.

Authors:  Teresa J Chan; Steven K Libutti; J Andrea McCart; Clara Chen; Anjum Khan; Monica K Skarulis; Lee S Weinstein; John L Doppman; Stephen J Marx; H Richard Alexander
Journal:  World J Surg       Date:  2003-05-13       Impact factor: 3.352

7.  A prospective trial evaluating a standard approach to reoperation for missed parathyroid adenoma.

Authors:  N Jaskowiak; J A Norton; H R Alexander; J L Doppman; T Shawker; M Skarulis; S Marx; A Spiegel; D L Fraker
Journal:  Ann Surg       Date:  1996-09       Impact factor: 12.969

Review 8.  Pre-operative localization and interventional treatment of parathyroid tumors: when and how?

Authors:  D L Miller
Journal:  World J Surg       Date:  1991 Nov-Dec       Impact factor: 3.352

9.  Intraoperative jugular venous sampling AIDS detection of an undescended parathyroid adenoma.

Authors:  Lawrence S Lee; Robert J Canter; Douglas L Fraker
Journal:  World J Surg       Date:  2006-04       Impact factor: 3.352

  9 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.